Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
Intervention1: Group A: Study Group (Unani Drug group): JawaÌ?rish falafili:
Method of Preparation-
The drug will be prepared in single batch on the guidelines and method of preparation described in
Sponsors
Central Research Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Participants of any sex aged 30-60 years. Participants with having following lipid or lipoprotein abnormality in blood- - Serum Cholesterol equal to or more than 200mg/dl. - HDL-C less than 40 mg/dl - LDL Cholesterol equal to or more than 130 mg/dl. - Serum Triglycerides level equal to or more than 150mg/dl. Both obese and non-obese.
Exclusion criteria
Exclusion criteria: Participants aged less than 30 and more than 60 years. Participants having a co-morbid condition like IHD, HT, Diabetes, etc. Participants having a major systemic disorder which interferes in the present study. Pregnant or Lactating Women. Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction Known cases of Immunocompromised states (HIV/ AIDS, etc.)/Malignancies Participant not willing to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical assessment of the change in Lipid and Lipoprotein levelTimepoint: At baseline, 2nd, 3rd and 4th followups | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemogram LFT, RFT, FPG, ECG and Urine R/M examinationTimepoint: At baseline, 3rd followup and after treatment, except ECG that will be at baseline and after treatment | — |
Countries
India
Contacts
Public ContactQamar Uddin
Central Research Institute of Unani Medicine
Outcome results
None listed